Stockscreener 앱 받기
32.60
7.56%
2.29
시장 영업 전:
33.11
0.51
+1.56%
전일 마감가:
$30.31
열려 있는:
$30.33
하루 거래량:
4.61M
Relative Volume:
2.95
시가총액:
$2.44B
수익:
$254.91M
순이익/손실:
$-103.48M
주가수익비율:
-23.23
EPS:
-1.4036
순현금흐름:
$-148.35M
1주 성능:
+10.51%
1개월 성능:
+62.27%
6개월 성능:
+181.52%
1년 성능:
+58.33%
1일 변동 폭
$29.56
$33.09
1주일 범위
$29.04
$33.09
52주 변동 폭
$10.95
$33.09
슈뢰딩거 Stock (SDGR) Company Profile
명칭
Schrodinger Inc
전화
503-299-1150
주소
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, TEM, TXG, BTSG, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
32.60 | 2.16B | 254.91M | -103.48M | -148.35M | -1.4036 |
VEEV
Veeva Systems Inc
|
283.45 | 45.44B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
83.55 | 15.43B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
97.74 | 11.17B | 638.78M | -22.66M | 122.18M | -0.1744 |
BTSG
Brightspring Health Services Inc
|
62.00 | 11.20B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
98.35 | 7.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
슈뢰딩거 Stock (SDGR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-09-30 | 개시 | Goldman | Neutral |
| 2025-08-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-14 | 개시 | Barclays | Overweight |
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-07-02 | 개시 | Leerink Partners | Outperform |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | 재개 | Piper Sandler | Overweight |
| 2022-12-19 | 개시 | Goldman | Neutral |
| 2022-03-01 | 개시 | Citigroup | Buy |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-11-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-10-13 | 개시 | Berenberg | Buy |
| 2021-09-01 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | 개시 | Craig Hallum | Buy |
| 2020-11-23 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-10-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-02 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-02 | 개시 | Jefferies | Hold |
| 2020-03-02 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
슈뢰딩거 주식(SDGR)의 최신 뉴스
Schrodinger, Inc. (SDGR) Stock Forecasts - Yahoo Finance
Schrodinger stock hits 52-week high at 31.69 USD By Investing.com - Investing.com Australia
Price to book forward of Schrodinger, Inc. – HAN:43Z - TradingView
ETFs Investing in Schrodinger, Inc. Stocks - TradingView
These ten healthcare stocks posted the biggest September gains - TradingView
43Z.SG Interactive Stock Chart | Schrodinger Inc. Stock - Yahoo Finance
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View - Yahoo Finance
Schrodinger Stock Price Forecast. Should You Buy SDGR? - StockInvest.us
Schrödinger, Inc. (SDGR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth? - TradingView
Schrödinger stock falls 4.79 percent as ACV growth reaches 27 percent - AD HOC NEWS
Schrödinger Drops 7.6% Amid Sector-Wide Selling - AlphaStreet
A Look at Schrodinger Inc (SDGR) After 4.8% Decline -- GF Value $24.26 vs Price $29.23 - GuruFocus
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs - inkl
Precision Trading with Schrodinger Inc. (SDGR) Risk Zones - Stock Traders Daily
Biosimulation Market Set for Strong Growth Through 2035, Fueled by AI-Driven Drug Discovery, Virtual Trials and Precision Medicine Demand - GlobeNewswire Inc.
Layoff Tracker: Novo workforce down 13,000 - BioSpace
Schrodinger stock gains 69.1 percent year to date - AD HOC NEWS
Schrodinger president Karen Akinsanya sells $927,970 in company stock By Investing.com - Investing.com Nigeria
Schrodinger president Karen Akinsanya sells $927,970 in company stock - Investing.com
Options at $4.34 become shares sold near $30 for Schrodinger (SDGR) insider - Stock Titan
Schrodinger Insider Sold Shares Worth $927,970, According to a Recent SEC Filing - Yahoo Finance
Schrodinger Inc. (SDGR) Pulls Back 4.03% to $29.02, Nearing Key SupportReversal Setup Alerts - siam.in
SDGR Q2 2026 Earnings: EPS Swings to Profit, Beating Estimates by 116%Estimate Revision Count - careplusvn.com
Schrödinger, Inc. Partners with NEA and RA Capital Management to Co-Found Tectora - Labroots
Schrodinger Inc. (SDGR) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Schrodinger Inc (SDGR) Shares Fall 4.0% -- GF Value Says Still O - GuruFocus
Schrödinger options flow points to bullish positioning ahead of potential catalyst - Investing.com
Schrodinger Inc (SDGR) Stock Up 26.4% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Schrödinger (SDGR) Stock Surges 60% but $37 Resistance Could Test the Rally as Mixed Fundamentals Raise Fresh Risks - FXLeaders
Insider at Schrodinger (NASDAQ: SDGR) plans September 2026 stock sale - Stock Titan
Schrödinger (SDGR) Surges 13.5% to $27.15 - AlphaStreet
$Schrodinger (SDGR.US)$ what happened?[Blush] - Moomoo
Schrödinger: Company Creation Is Now The Real Drug Business (NASDAQ:SDGR) - Seeking Alpha
SDGR Looks 3.2% Undervalued on GF Value™ - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Schrödinger (SDGR) Rallies On Tectora Deal But Is The Upside Already Priced In - simplywall.st
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock? - finance.yahoo.com
SDGR Looks 5.9% Undervalued on GF Value™ as AI-Driven Surge Lifts Shares - GuruFocus
Schrödinger jumps 12% to new 52-week high amid AI drug-discovery interest (SDGR:NASDAQ) - Seeking Alpha
Schrodinger Inc stock hits 52-week high at 23.06 USD By Investing.com - Investing.com Australia
Schrodinger Inc stock hits 52-week high at 23.06 USD - Investing.com
SDGR: AI-driven platform innovation and hosted solutions fuel growth, with profitability targeted by 2028 - TradingView
Understanding the Setup: (SDGR) and Scalable Risk - Stock Traders Daily
Schrödinger introduces Tectora Therapeutics - BioWorld News
Tectora Therapeutics inc. announced that it has received $55 million in funding from New Enterprise Associates, Inc., RA Capital Management, L.P., Schrödinger, Inc. - marketscreener.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs - BioSpace
SDGR Looks 19.2% Undervalued on GF Value™ - GuruFocus
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates - marketscreener.com
A new drug company raises $55 million for oral medicines - Stock Titan
Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics - Fierce Biotech
슈뢰딩거 (SDGR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
슈뢰딩거 주식 (SDGR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Akinsanya Karen | See Remarks |
Sep 17 '26 |
Sale |
29.37 |
31,599 |
927,970 |
69,956 |
0.08%
5.86%
자본화:
|
볼륨(24시간):